Most think that for the approximately 2.8 million adults in the U.S. that are living with schizophrenia, life is permanently disrupted, every day is anticipating the next crisis or onset of intense symptoms, and it’s not worth planning for the future.
Despite schizophrenia being a complex and chronic brain disorder characterized by distortions in thinking, perceptions, emotions, language, and behavior, there is hope for people living with this condition to lead a normal life. Not many people living with schizophrenia or their loved ones know that long-acting injectable (LAI) treatments for schizophrenia offer potential advantages over oral medications.
This includes providing long-acting symptom control in each dose without the burden of a daily medication, improved patient outcomes, and delayed time to episodes of symptom relapse. This can allow adults living with schizophrenia to focus less on daily treatment management and more on the things that are important to them.
On May 23rd, ahead of World Schizophrenia Day (May 24th), certified psychiatric mental health nurse practitioner, and clinician regularly treating patients living with schizophrenia, Jonathan Llamas PMHNP-BC, will be available to discuss:
The obstacles his patients face managing schizophrenia symptoms and the importance of understanding that recovery is possible.
How he cultivates a positive and culturally sensitive patient-provider relationship and helps patients find a treatment regimen that’s tailored to their specific treatment goals and lifestyle.
How a specific LAI treatment option can enable adults living with schizophrenia to focus more on the things in life that are important to them.
Interview is courtesy: Janssen Pharmaceuticals, Inc.. : www.janssenschizophreniainjections.com/
Footnotes available
